Literature DB >> 25785133

Early- and late-onset severe pneumonia after renal transplantation.

Guowei Tu1, Minjie Ju1, Yijun Zheng1, Ming Xu2, Ruiming Rong2, Duming Zhu1, Tongyu Zhu2, Zhe Luo1.   

Abstract

BACKGROUND: The aim of this study was to clarify the distinctions in the clinical characteristics and outcomes between early- and late-onset severe pneumonia after renal transplantation requiring ICU admission.
METHODS: The data were retrospectively collected in consecutive renal recipients with severe pneumonia from January 1, 2009, to December 31, 2013, in a tertiary ICU. We classified the patients according to the time of pneumonia onset as follows: early-onset severe pneumonia (E-SP) corresponded to a pulmonary infection occurring during the first year following the transplantation, and late-onset severe pneumonia (L-SP) corresponded to a pulmonary infection occurring after the first year following the transplantation.
RESULTS: In the E-SP patients, fungi (42.1%) and viruses (31.6%) were the most common pathogens. Twenty-three (71.9%) patients received non-invasive ventilation (NIV), 15 (65.2%) of whom were intubated. The median duration of the ICU and hospital stays was 11 ± 5 and 19 ± 4 days, respectively. In the L-SP patients, bacteria (42.1%) and viruses (26.3%) were the predominant pathogens. Four of 15 (26.7%) patients failed NIV treatment. The median duration of the ICU and hospital stays was 9 ± 3 and 16 ± 3 days, respectively. The ICU mortality among the E-SP patients was 18.8% (6 of 32), compared with 7.1% (2 of 28) in the L-SP group (P = 0.264).
CONCLUSIONS: Early-onset severe pneumonia in renal transplant recipients resulted in a more serious condition, higher rate of NIV failure, longer duration of mechanical ventilation, and increased length of ICU and hospital stays.

Entities:  

Keywords:  Renal transplantation; mechanical ventilation; non-invasive ventilation; severe pneumonia

Year:  2015        PMID: 25785133      PMCID: PMC4358588     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  21 in total

1.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

2.  Epidemiology of pneumonia in kidney transplantation.

Authors:  I Hoyo; L Linares; C Cervera; M Almela; M A Marcos; G Sanclemente; F Cofán; M J Ricart; A Moreno
Journal:  Transplant Proc       Date:  2010-10       Impact factor: 1.066

3.  Moderate-dose glucocorticoids as salvage therapy for severe pneumonia in renal transplant recipients: a single-center feasibility study.

Authors:  Guo-Wei Tu; Min-Jie Ju; Yan Han; Hong-Yu He; Rui-Ming Rong; Ming Xu; Zhang-Gang Xue; Tong-Yu Zhu; Zhe Luo
Journal:  Ren Fail       Date:  2013-10-30       Impact factor: 2.606

4.  Late-onset Pneumocystis jirovecii pneumonia in solid organ transplant recipients.

Authors:  L Perez-Ordoño; I Hoyo; G Sanclemente; M J Ricart; F Cofan; F Perez-Villa; J Puig de la Bellacasa; A Moreno; C Cervera
Journal:  Transpl Infect Dis       Date:  2014-01-24       Impact factor: 2.228

Review 5.  Infection in organ transplantation: risk factors and evolving patterns of infection.

Authors:  Jay A Fishman; Nicolas C Issa
Journal:  Infect Dis Clin North Am       Date:  2010-06       Impact factor: 5.982

6.  Cytomegalovirus disease in kidney transplant recipients: incidence, clinical profile, and risk factors.

Authors:  E Cordero; C Casasola; R Ecarma; R Danguilan
Journal:  Transplant Proc       Date:  2012-04       Impact factor: 1.066

Review 7.  Toxicity and monitoring of immunosuppressive therapy used in systemic autoimmune diseases.

Authors:  Keith C Meyer; Catherine Decker; Robert Baughman
Journal:  Clin Chest Med       Date:  2010-09       Impact factor: 2.878

8.  Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued?

Authors:  S M Gordon; S P LaRosa; S Kalmadi; A C Arroliga; R K Avery; L Truesdell-LaRosa; D L Longworth
Journal:  Clin Infect Dis       Date:  1999-02       Impact factor: 9.079

9.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

10.  Acute respiratory distress syndrome: the Berlin Definition.

Authors:  V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

View more
  5 in total

1.  Lactate dehydrogenase as a prognostic marker of renal transplant recipients with severe community-acquired pneumonia: a 10-year retrospective study.

Authors:  Ying Su; Min-Jie Ju; Jie-Fei Ma; Guo-Wei Tu; Hong-Yu He; Zhun-Yong Gu; Yuan-Lin Song; Jing Zhang; Zhe Luo
Journal:  Ann Transl Med       Date:  2019-11

2.  The Management of Immunosuppression in Kidney Transplant Recipients with COVID-19 Disease: An Update and Systematic Review of the Literature.

Authors:  Roberta Angelico; Francesca Blasi; Tommaso Maria Manzia; Luca Toti; Giuseppe Tisone; Roberto Cacciola
Journal:  Medicina (Kaunas)       Date:  2021-04-30       Impact factor: 2.430

3.  Association Between Red Blood Cell Distribution Width and Prognosis of Renal Transplant Recipients with Early-Onset Pneumonia.

Authors:  Yingzi Ming; Min Yang; Bo Peng; Quan Zhuang; George B Stefano; Richard M Kream; Hong Liu
Journal:  Med Sci Monit       Date:  2019-09-04

Review 4.  Acute respiratory failure in immunocompromised adults.

Authors:  Elie Azoulay; Djamel Mokart; Achille Kouatchet; Alexandre Demoule; Virginie Lemiale
Journal:  Lancet Respir Med       Date:  2018-12-07       Impact factor: 30.700

5.  Glucocorticoid attenuates acute lung injury through induction of type 2 macrophage.

Authors:  Guo-Wei Tu; Yi Shi; Yi-Jun Zheng; Min-Jie Ju; Hong-Yu He; Guo-Guang Ma; Guang-Wei Hao; Zhe Luo
Journal:  J Transl Med       Date:  2017-08-29       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.